LAC Med Berhad (KLSE:LACMED)

LAC Med Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	40.05	30.55	15.84	30.45	23.83
Short-Term Investments	28.94	52.49	27.74	2.94	0.95
Cash & Short-Term Investments	68.99	83.04	43.58	33.39	24.77
Cash Growth	135.02%	90.52%	30.51%	34.80%	-
Accounts Receivable	98.6	80.14	38.74	68.73	50.96
Other Receivables	12.39	1.13	0.42	0.38	0.29
Receivables	110.98	81.27	39.16	69.11	51.24
Inventory	31.66	27.78	20.8	21.61	10.84
Prepaid Expenses	-	0.67	0.42	0.13	0.08
Other Current Assets	-	7.79	20.02	11.88	14.08
Total Current Assets	211.63	200.54	123.99	136.12	101.02
Property, Plant & Equipment	11.75	9.81	1.46	1.36	0.6
Other Intangible Assets	2.54	2.83	-	-	-
Long-Term Deferred Tax Assets	2.58	2.04	2.66	2.13	1.63
Total Assets	228.5	215.23	128.11	139.61	103.25

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accounts Payable	44.19	38.6	28.74	37.53	19.28
Accrued Expenses	-	5.34	3.62	4.16	1.42
Short-Term Debt	32.01	20.93	18.15	22.43	31.25
Current Portion of Long-Term Debt	0.17	0.17	0.77	0.82	0.77
Current Portion of Leases	1.56	0.17	0.11	0.15	0.12
Current Income Taxes Payable	0.01	2.91	2.1	1.84	1.99
Current Unearned Revenue	6.38	7.47	13.96	16.36	12.22
Other Current Liabilities	15.61	19.55	11.36	14.2	7.98
Total Current Liabilities	99.92	95.15	78.81	97.47	75.02
Long-Term Debt	0.97	1.07	1.3	2.06	2.88
Long-Term Leases	5.06	0.11	0.1	0.21	0.23
Total Liabilities	106	96.32	80.21	99.75	78.13

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	102.2	102.2	2	2	2
Retained Earnings	66.45	62.75	45.77	37.87	23.12
Comprehensive Income & Other	-46.15	-46.11	-0	-	-
Total Common Equity	122.5	118.84	47.76	39.87	25.12
Minority Interest	0	0.06	0.14	-	-
Shareholders' Equity	122.5	118.91	47.9	39.87	25.12
Total Liabilities & Equity	228.5	215.23	128.11	139.61	103.25

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	39.77	22.45	20.42	25.67	35.24
Net Cash (Debt)	29.22	60.58	23.16	7.72	-10.47
Net Cash Growth	115.13%	161.57%	199.90%	-	-
Net Cash Per Share	0.25	0.52	11.58	3.86	-5.23
Filing Date Shares Outstanding	400	400	2	2	2
Total Common Shares Outstanding	400	400	2	2	2
Working Capital	111.71	105.4	45.17	38.65	26
Book Value Per Share	0.31	0.30	23.88	19.93	12.56
Tangible Book Value	119.96	116.01	47.76	39.87	25.12
Tangible Book Value Per Share	0.30	0.29	23.88	19.93	12.56
Machinery	-	11.15	2.05	1.67	1.17
Order Backlog	-	216.7	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 19, 2026

Data Sources Report a data error